Using Enhanced Peer Group Strategies to Support Option B+ in Uganda

在乌干达使用增强的同侪群体策略支持选项 B

• 批准号: 8729113
• 负责人: MARY Glenn Fowler
• 金额: $ 60.64万
• 依托单位: MU-JHU CARE
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2019-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8729113
• 关键词: AIDS prevention; Adherence; Adopted; Africa South of the Sahara; Anti-Retroviral Agents; Antiretroviral resistance; Appointment; Attitude; Blood; Breast Feeding; CD4 Lymphocyte Count; Caring; Cessation of life; Child; Client; Clinic; Clinical; Communities; Counseling; Country; Couples; Data; Diagnosis; Disclosure; Dose; Effectiveness; Enrollment; Evaluable Disease; Family; Family Planning; Focus Groups; Fostering; Friends; Goals; Guidelines; HIV; Hair; Health; Health Benefit; Health Policy; Health education; Hospitals; Income; Individual; Infant; Intervention; Learning; Life; Location; Long-Term Care; Maps; Maternal Health; Measures; Mothers; Participant; Patient Self-Report; Peer Group; Personal Satisfaction; Pharmaceutical Preparations; Plasma; Policies; Policy Maker; Postpartum Period; Pregnancy; Pregnant Women; Prevention; Randomized; Randomized Clinical Trials; Randomized Controlled Trials; Regimen; Reporting; Research; Resources; Risk; Rural; Sampling; Services; Sexual Transmission; Site; Support System; System; Time; Travel; Uganda; Update; Viral; Viral Load result; Visit; Woman; World Health Organization; antiretroviral therapy; arm; base; drug distribution; economic outcome; empowered; falls; feeding; follow-up; group support; health economics; improved; innovation; male; meetings; nutrition; nutrition education; open label; peer; pregnant; primary outcome; programs; prophylactic; psychosocial; public health relevance; randomized trial; research study; residence; scale up; screening; standard of care; success; therapy design; transmission process; trial comparing

DESCRIPTION (provided by applicant): The Uganda's Ministry of Health (MOH) in October 2012 adopted Option B+ (life-long triple antiretroviral therapy [ART]) for the prevention of mother-to-child HIV transmission (PMTCT). The national scale up of option B+ provides an opportunity to eliminate mother-to-child HIV transmission (MTCT) in Uganda. However, adherence to life-long triple ART by HIV-infected pregnant women in resource-limited settings presents unique challenges given disruptions in normal routines often with travel upcountry and difficulties of life time adherence among generally healthy women after the risk of transmitting HIV to their infant has ceased. The overall goal of this operational research to be conducted in urban and rural Uganda is to improve adherence to option B Plus among HIV-infected pregnant and newly delivered mothers. We will use formative research followed by a randomized clinical trial of an enhanced compare a community based intervention to improve maternal adherence to appointments and taking ARVs. Our hypothesis is that the community-based peer group support strategy called 'Friends for Life Circles' combining drug access, health education and income- generating activities will be more effective to support women to adhere to their treatment and care visits and to their drugs to achieve and maintain viral suppression and minimize MTCT of HIV when compared to the current MOH approach to support mothers adherence to option B+. The specific aims of this operational research are: AIM 1: To conduct formative research to assess individual, family and community attitudes regarding Option B plus. AIM 2: To conduct a randomized controlled trial that compares community-based peer group support versus Ministry of Health hospital-based standard of care for Option B plus. AIM 3: To evaluate the adherence to option B plus and effectiveness of the community- based peer group support intervention compared to Ministry of Health hospital-based standard of care for Option B plus. The formative research will inform the implementation of the community-based group peer support intervention. The research will be conducted as a randomized clinical trial. A total of 540 evaluable HIV-infected women enrolled during pregnancy will be randomized to either Friends for Life Circles (FLC) or the standard MOH counseling on adherence in a rural and an urban district of Central Uganda. HIV-infected women assigned to the group peer support (FLC) arm will meet on a monthly basis in the community and participate in the circles. Group sessions will include drug distribution, counseling on adherence to ARVs and follow-up visits, male partner disclosure, infant feeding and nutrition, and promotion of psychosocial well-being. Income-generating activities will be used to foster sustainability of the Circles after the period of risk of transmission of HIV to the infant has ceased. In partnership with the MOH, the findings from the Friends for Life Circles will be evaluated and the successful components and lessons learned will be documented to inform the scaling up of the intervention within the districts and nationally.

描述（由申请人提供）：乌干达卫生部（MOH）于2012年10月通过了方案B+（终身三联抗逆转录病毒疗法[ART]），用于预防母婴艾滋病毒传播（PMTCT）。在全国推广备选方案B+为在乌干达消除母婴艾滋病毒传播提供了机会。然而，由于通常需要前往内地，正常生活会受到干扰，而且在将艾滋病毒传播给婴儿的风险消失后，一般健康的妇女很难终生坚持接受三重抗逆转录病毒治疗，因此，在资源有限的环境中，感染艾滋病毒的孕妇终生坚持三重抗逆转录病毒治疗面临着独特的挑战。这项业务研究将在乌干达城市和农村进行，其总体目标是提高感染艾滋病毒的孕妇和刚分娩的母亲对备选方案B Plus的坚持程度。我们将使用形成性研究，然后是一个增强的随机临床试验，比较一个基于社区的干预措施，以提高产妇坚持预约和服用抗逆转录病毒药物。我们的假设是，与卫生部目前支持母亲坚持选择B+的方法相比，以社区为基础的同伴群体支持战略“生命圈之友”将药物获取、健康教育和创收活动结合起来，将更有效地支持妇女坚持接受治疗和护理，坚持使用药物，以实现和维持病毒抑制，尽量减少艾滋病毒的母婴传播。 这项业务研究的具体目标是：目标1：进行形成性研究，以评估个人、家庭和社区对方案B+的态度。目标2：进行一项随机对照试验，比较基于社区的同伴群体支持与卫生部基于医院的标准治疗方案B plus。目标3：评价对方案B plus的依从性以及与卫生部基于医院的方案B plus护理标准相比，基于社区的同伴群体支持干预的有效性。形成性研究将为社区小组同伴支持干预的实施提供信息。该研究将作为随机临床试验进行。在乌干达中部的一个农村和一个城市地区，共有540名在怀孕期间登记的可评价的艾滋病毒感染妇女将被随机分配到生活之友圈（FLC）或标准的卫生部咨询。被分配到同伴互助小组的感染艾滋病毒的妇女将每月在社区聚会并参加圈子。小组会议将包括药物分发、关于坚持使用抗逆转录病毒药物的咨询和后续访问、男性伴侣披露、婴儿喂养和营养以及促进心理健康。在艾滋病毒传染给婴儿的风险期结束后，将利用创收活动来促进这些圈子的可持续性。将与卫生部合作，对“生命之友”的调查结果进行评估，并将成功的组成部分和吸取的经验教训记录在案，以便为在各地区和全国范围内扩大干预行动提供信息。